Large US IDN Drug-Eluting Stents
Share
Share

Large U.S. IDN sourcing drug-eluting stents from multiple vendors, resulting in wide price variances by region. MD Buyline assembled four pricing models and recommended elimination of Paclitaxel stents to reduce adverse outcomes. Identified $15.8 million in savings.

We use cookies and other tracking technologies to improve your browsing experience on our website, to show you personalized content and targeted ads, to analyze our website traffic, and to understand where our visitors are coming from. By browsing our website, you consent to our use of cookies and other tracking technologies.
Thanks for signing up. You must confirm your email address before we can send you. Please check your email and follow the instructions.
×
×